Introduction
In the Indian subcontinent, patients having multivalvular disease (MVD) continue to be a frequent entity whose evaluation and management are challenging. MVD is the combination of stenosis or regurgitation, or both, on two or more valves of the heart. 1 There are a large number of possible combinations in patients with MVD, and this heterogeneity leads to availability of limited data.
2,3 The
European Society of Cardiology (ESC) guidelines in 2012 stated that there is a lack of data on mixed and multiple valvular heart disease, and this does not allow for evidencebased recommendations. 2 Although each case of MVD is different, in this review we consider the general pathophysiologic principles, assess the clinical and echocardiographic challenges to the anesthesiologist in MVD, and the potential management strategies.
Incidence and Etiology
In developing countries, rheumatic heart disease (RHD) continues to be the main etiology, whereas degenerative etiologies are increasing in developed countries. 1, 4 In 2011, the Society of Thoracic Surgeons (STS) reported 10.9% of the patients undergoing valve surgery to have multiple-valve intervention in North America. 5 In the Euro Heart Survey conducted in 2001 in 25 countries, 20.2% of the patients with native valve disease and 14.6% of the patients undergoing valvular surgery had MVD. 6 In this survey, RHD was found to be the most frequent etiology (51.4%) of MVD, followed by degenerative valve disease (40.6%). 6 The other causes of primary MVD include endocardi-
Pathophysiology
The natural history of MVD is determined by the relative severity of each individual lesion and the chronology and the chronicity of development. In such patients, the manifestation of proximal valve disease can obscure the manifestation of distal valve lesion. 7 In addition, the consequences of various combinations of diseased valves on left ventricular (LV) and right ventricular (RV) geometry and function are generally different from the remodeling because of singlevalve disease.
Echocardiographic Pitfalls in Evaluation of Multivalvular Disease
Echocardiography is one of the mainstays in the evaluation of patients with valvular heart disease. Third, patients with AS can have concomitant primary MR. Severe AS in association with significant MR is, however, one of the least common combinations of valvular lesions in RHD.
Pathophysiology
In patients having AS, the severity of MR increases with time because of several mechanisms, such as increase in the LV to left atrial (LA) pressure gradient, leading to increase in the regurgitant volume for any given ERO area, LV remodeling that may promote MV deformation, etc. 9 MR contributes to a low-flow state in patients with AS. 10 The presence of MR, whether primary or secondary, can alter the clinical presentation of patients with AS.
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Echocardiographic Pitfalls
As described in pathophysiology, the systolic transmitral pressure gradient is increased due to AS, and hence, the echocardiographic measurements of regurgitant flow and the regurgitant volume will be increased for any given mitral regurgitant orifice area. 11 There will be an increased area of mitral regurgitant jet using color-flow Doppler. In patients having secondary MR, the AHA/ACC 2014 guidelines recommend that the measurement of the proximal isovelocity surface area by two-dimensional (2D) echocardiography underestimates the true ERO because of the crescentic shape of the proximal convergence. 12 The presence of MR, on the contrary, will lead to low flow, low gradient across the aortic valve. 
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Aortic Stenosis and Mitral Stenosis
Clinical Scenario
In the Indian subcontinent, significant stenosis at multiple valves is usually due to RHD. Patients with degenerating AS can have progressive mitral annular calcification leading to degenerating mitral valve stenosis. 16 Other causes include Shone's complex, mucopolysaccharidosis, etc.
Pathophysiology
The clinical signs of upstream lesion that is mitral stenosis (MS) usually prevails. 7 If atrial fibrillation develops in such a scenario, it is poorly tolerated by the patient.
Echocardiographic Pitfalls
The severity of MS is usually not affected by the presence of AS, but the gradients across the aortic valve may be reduced, resulting in low-flow, low-gradient AS and potential underestimation of AS severity. 7 LV abnormal relaxation resulting from AS will increase the mitral E-wave pressure half-time.
The pressure half-time method used to estimate the severity of MS is unreliable in the presence of AS. Planimetry continues to be the standard method to assess mitral area, but heavy calcifications can impair its measurement also.
Guideline-Directed Management
The salient features of management in such scenario is described in ►Table 2. The AHA/ACC guidelines mainly refer to rheumatic mitral valve disease, and the approach to degenerative mitral valve disease may differ. 8 In patients with severe AS undergoing TAVI, the concomitant MS is generally of degenerative etiology, and usually, there is no commissural fusion, and is therefore not suitable for percutaneous mitral commissurotomy.
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Aortic Regurgitation and Mitral Stenosis
Clinical Scenario
Combined aortic regurgitation (AR) and MS in the adult age group usually reflect the natural progression of valve lesions following rheumatic fever in the Indian scenario.
18
Pathophysiology
In isolated MS, LV preload and diastolic pressure are reduced as a function of the severity of inflow obstruction. However, because of AR, the diastolic pressure may rise depending on the compliance. The combination of aortic regurgitation and MS results in opposite loading conditions on the LV. As the cardiac output falls with progressive degrees of MS, transaortic valve flows will decline, masking the potential severity of the aortic valve lesion, and hence, the clinical signs such as increased pulse pressure might not be observed.
Echocardiographic Pitfall
AR shortens directly measured pressure half-time proportional to the regurgitant fraction, but an increase in left ventricular compliance could offset this effect. This shortening of pressure half-time leads to mitral valve area overestimation, 19, 20 Mitral valve area should not be measured from continuity equation method in the presence of AR, because the transmitral flow differs from the transaortic flow.
20
Guideline-Directed Management
The guideline for managing this combination is mentioned in ►Table 3.
Aortic Regurgitation and Mitral Regurgitation
Clinical Scenario 
Echocardiographic Pitfall
The use of Doppler volumetric method is not validated. 
Guideline-Directed Management
In treating combined AR and MR, the incomplete reversibility of left ventricular dilatation due to AR should be kept in mind. If indications for AVR are fulfilled, concomitant mitral valve repair should be considered. ESC 2012 guideline states that If AR requiring surgery is associated with severe MR, both should be operated on.
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Mixed Aortic Valve Disease
There is paucity of data about the natural history of combined AS and AR, making evidence-based recommendations regarding AVR challenging. 22 In clinical practice, the management of patients with combined aortic valve disease usually follows the recommendations of the predominant lesion. 2 The current indications for surgery have been defined for single-valve disease and are "extrapolated" to patients with mixed-valve disease. The peak aortic velocity is a reliable prognostic indicator for isolated AS, 23 but in combined disease, it is likely to overestimate the severity of stenosis because of increased stroke volume. This increased velocity will also lead to increased LV aortic Doppler-derived pressure gradient to values higher than expected for the true systolic valve orifice size as measured by planimetry. The pressure half-time used for evaluating AR may be prolonged when left ventricular hypertrophy with impaired relaxation is present due to AS. Thus the quantification of the severity of combined aortic valve disease is complex as the measures of severity are affected by the coexisting lesion.
3 Aortic valve area may not provide required information as it reflects the severity of AS only, and not accounting for the severity of AR.
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Mixed Mitral Valve Disease
Similar to the aforementioned mixed aortic valve disease, in mixed mitral valve disease the peak mitral valve E-wave velocity may be increased. In the setting of severe MR because of enhanced early-diastolic flow, the peak mitral valve E-wave velocity may not accurately reflect the contribution to LA hypertension from any associated MS. When AR or MR is the dominant lesion in patients with mixed aortic or mitral valve disease, respectively, the LV is dilated. When AS or MS predominates, LV chamber size will be normal or small. Also, the presence of moderate or severe MR in patients with rheumatic MS is a contraindication to percutaneous mitral balloon valvotomy (PMBV). 
Conclusion
The thorough understanding of the pathophysiology and the echocardiographic challenges will help in better management of the various situations arising from different combinations of the valve lesions in patients with MVD. It is important to understand both the diagnostic and therapeutic challenges in such clinical scenarios. The global consequences of all lesions should be considered before any decision making. The perioperative risk and benefits of double-valve surgical intervention should be considered on a case-by-case basis. The use of percutaneous intervention in patients with MVD is in its infancy, but the future development of transcatheter techniques will offer the possibility of staged procedures in high-risk patients. 
